Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2010
11/10/2010CN1798840B Nogo受体结合蛋白 Nogo receptor-binding protein
11/10/2010CN101883862A Method for production of antibody
11/10/2010CN101883851A Identification and isolation of fetal cells and nucleic acid
11/10/2010CN101883850A Methods and compositions for inactivating alpha-1,6 fucosyltransferase (FUT 8) gene expression
11/10/2010CN101883844A Method and kit for rapid isolation of human foxp3+ treg cells
11/10/2010CN101883793A Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the C1 domain of factor VIII
11/10/2010CN101883792A New antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs
11/10/2010CN101883791A Humanized antibody
11/10/2010CN101883790A Use of anti-amyloid beta antibody in ocular diseases
11/10/2010CN101883789A Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
11/10/2010CN101883788A Polypeptides, antibody variable domains and antagonists
11/10/2010CN101883786A Compositions of humanized NOTCH fusion proteins and methods of treatment
11/10/2010CN101880325A Monoclonal antibody for detecting imidacloprid pesticide residue
11/10/2010CN101880324A Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
11/10/2010CN101880323A Preparation method for anti-hand-foot-and-mouth-disease specific egg yolk antibody
11/10/2010CN101880322A Co-production process for immune globulin and high-density lipoprotein in poultry egg yolk
11/10/2010CN101880318A Virus protein granules of hepatitis E virus-4 ORF2 fragment and prepration method and application thereof
11/10/2010CN101880316A Human RBPMS polypeptide and preparation method of antibody thereof
11/10/2010CN101880313A Method for separating and purifying antibodies
11/10/2010CN101205528B Spiro protomer strain and uses thereof
11/10/2010CN101092456B Gene engineering antibody of human source neutrality for anti virus H5N1 of bird flu
11/10/2010CN101012239B Fenitrothion hapten, artificial antigen, specified antibody and use thereof
11/10/2010CA2759233A1 Method for making heteromultimeric molecules
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829678 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
11/09/2010US7829677 Antibodies that recognize hyperproliferative cells and methods of making and using same
11/09/2010US7829676 Whitefly ecdysone receptor antibody
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829674 Compositions and methods for binding sphingosine-1-phosphate
11/09/2010US7829673 comprises a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:7 or encoded by the nucleotide sequence set forth in SEQ ID NO:6; inhibiting growth and/or proliferation of a cell expressing CD38; kits
11/09/2010US7829672 Modulation of sodium channels in dorsal root ganglia
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829294 antibody against a soluble fibrin, which does not react with fibrinogen but specifically recognizes a conformation-changed site newly occurred in a C-terminal region of an A alpha -chain of the soluble fibrin formed through thrombin digestion of fibrinogen; disseminated intravascular coagulation
11/09/2010US7829293 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders
11/09/2010US7829096 CD40L-specific monovalent polypeptides
11/09/2010US7829095 Produced by hybridoma cell line DSM ACC 2533
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829091 Therapy targeting FLT4 (VEGER-3) expressed in blood vessels
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010US7829089 Antibody to mammalian cytokine-like polypeptide-10
11/09/2010US7829088 Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof
11/09/2010US7829086 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/09/2010US7829084 Molecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by autoantibody production
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/04/2010WO2010127258A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof
11/04/2010WO2010127252A2 Monoclonal antibodies to influenza h1n1 virus and uses thereof
11/04/2010WO2010127180A2 Dc-stamp antibodies
11/04/2010WO2010127069A1 Antibody purification
11/04/2010WO2010126972A1 Erg monoclonal antibodies
11/04/2010WO2010126653A1 Antibodies against delta-5 desaturase and uses thereof
11/04/2010WO2010126590A1 Ptp1b inhibitors
11/04/2010WO2010126452A1 Molecular signature of human lung cancer initiating cells and uses thereof
11/04/2010WO2010126279A2 Cytokeratin 17-specific human antibody
11/04/2010WO2010126278A2 Humanized nsg mouse, method of producing the same and use thereof
11/04/2010WO2010126115A1 Method for screening monoclonal antibody recognizing three-dimensional structure of membrane protein
11/04/2010WO2010126074A1 Pharmaceutical composition for maintenance therapy which contains antibody capable of recognizing hla class-i as active ingredient
11/04/2010WO2010126066A1 Anti-il-3rα antibody for use in treatment of blood tumor
11/04/2010WO2010125571A1 Anti ceacam1 antibodies and methods of using same
11/04/2010WO2010125565A2 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
11/04/2010WO2010125187A2 Method for the production of domain antibodies
11/04/2010WO2010125162A1 Anti cxcr4 antibodies for the treatment of hiv
11/04/2010WO2010125076A1 Immunoassay for the detection of procalcitonin
11/04/2010WO2010125003A1 Compositions and methods for increasing muscle growth
11/04/2010WO2010095031A3 Humanized antibodies that bind to cd19 and their uses
11/04/2010WO2010081173A3 Modified antibody compositions, methods of making and using thereof
11/04/2010WO2010080769A3 Chemotherapeutic methods and compositions
11/04/2010WO2010079850A3 Agent for prophylaxis or treatment of cancer
11/04/2010WO2010056966A3 Novel hiv-2 isolate
11/04/2010WO2010038974A9 Composition and kit for diagnosing immunoglobulin a nephropathy and tgbm nephropathy
11/04/2010WO2010036851A3 Single chain antibody library design
11/04/2010WO2010027903A8 Lung cancer diagnosis
11/04/2010WO2010017196A3 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
11/04/2010US20100281550 Factor involved in latent infection with herpesvirus, and use thereof
11/04/2010US20100280227 Polypeptides that bind br3 and uses thereof
11/04/2010US20100279947 Modifications of apoptin
11/04/2010US20100279940 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
11/04/2010US20100279932 Binding constructs and methods for use thereof
11/04/2010US20100279923 Therapeutic application of kazal-type serine protease inhibitors
11/04/2010US20100279400 Diagnostic test for west nile virus
11/04/2010US20100279399 Human Cancer Stem Cell Culture Compositions Comprising ErbB2 Variants and Methods of Use
11/04/2010US20100279364 CCI-779 derivatives and methods of making same
11/04/2010US20100279355 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/04/2010US20100279350 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
11/04/2010US20100279349 Nucleic acids encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor
11/04/2010US20100279333 Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
11/04/2010US20100279325 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
11/04/2010US20100279323 Method for predicting response to epidermal growth factor receptor-directed therapy
11/04/2010US20100279316 Antibodies to Phosphorylated IRAK4
11/04/2010US20100279313 Novel secreted immunomodulatory proteins and uses thereof
11/04/2010US20100279307 Angiogenesis Inhibiting Molecules, Their Selection, Production and Their Use in the Treatment of Cancer
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278875 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation
11/04/2010US20100278865 Production and use of epitope-tagged hepatitis c virus particle
11/04/2010US20100278856 BoNT/A PEPTIDES AND METHODSOF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY
11/04/2010US20100278853 Constrained hiv v3 loop peptides as novel immunogens and receptor antagonists
11/04/2010US20100278849 Prostatic acid phosphatase antigens